Tags » Chronic Lymphocytic Leukemia

FDA Approves Ofatumumab for Additional CLL Patients

The Backstory

On January 19, 2016, the FDA approved the use of ofatumumab to treat patients with recurrent or progressive chronic lymphocytic leukemia (CLL) who are in complete or partial response following at least two prior treatment therapies. 352 more words

Lymphoma News

FDA Expedites Review of New CLL Treatment

The Backstory

In May 2015, the Federal Drug Administration (FDA) granted venetoclax a breakthrough therapy designation for treating patients with relapsed or refractory chronic lymphocytic leukemia (CLL) with a specific genetic alteration – the 17p deletion. 410 more words

Lymphoma News

Dr. Richard Furman Joins Panel Discussion on CLL Prognostic Factors and the Impact on New Therapies

In this video from OncLive, CLL Program Director, Dr. Richard Furman joins a panel of chronic lymphocytic leukemia (CLL) experts to discuss the use of a new prognostic index for patients with CLL and its impact on new therapies. 278 more words

Lymphoma News

The Coloring Book Cancer Connection

As a long-term cancer survivor who’s been living with Chronic Lymphocytic Leukemia (CLL) since 1992, I’ve been looking for ways to manage stress and anxiety for a long time. 470 more words

Facing Cancer Together

11/1/15 Major Milestone Behind Me Now

A full seven years ago now that October has passed, I was sitting in Hemosapien‘s office, apprehensive, fearful, and more than a bit disbelieving that it was actually me as a patient waiting for a consultation with an oncologist. 2,982 more words

Mississippi Chris Sharp

My Journey

Good morning all, I have not written on this blog now for over a year. So I thought I would bring all of you up to date on my walk with SLL/CLL. 1,113 more words

Chronic Lymphocytic Leukemia

Clinical Care Options Article on Chronic Lymphocytic Leukemia

Clinical Care Options is an excellent educational website for physicians. I find their slides to be superb, and I use the slides to update myself on all the latest findings from the big meetings. 204 more words